Kathryn Mikkelsen Presents Vasculearn Network’s New Project – “Newly Diagnosed Email Campaign”
Kathryn Mikkelsen, Executive Director at Vasculearn Network, shared on LinkedIn:
”One of the new projects I’m incredibly proud of at Vasculearn Network is our “Newly Diagnosed Email Campaign,” a free resource for people who have just experienced a blood clot.
This automated drip campaign delivers two short emails per week, starting as soon as a patient signs up, with information designed to meet patients where they are and when they need it most in their recovery.
We hear time and time again in our support groups that, at the time of diagnosis, patients either: receive far too much information all at once, or not nearly enough to feel safe and confident.
This program was created to help solve that problem for both patients and healthcare professionals trying to counsel and educate during a high-stress moment.
The curriculum is based on work we published in Lancet Hematology, and we built it to be:
- evidence-based
- practical
- easy to digest
- and completely FREE
If you work in emergency medicine, hematology, cardiology, primary care, hospital medicine, or pharmacy, please feel free to include this link in discharge notes, visit summaries, or share it during follow-up visits.
And here‘s the Lancet Hematology publication that informed this work.
BONUS!
If you’d like flyers or business cards to hand out in clinic or on rounds, DM me and we’ll happily send them.
Helping patients feel informed, supported, and less alone shouldn’t be complicated or expensive.
I love that this is a simple, scalable solution to a very real gap in care.”
Read the full article here.
Article: Optimising communication to patients with venous thromboembolism: development of a provider toolkit
Authors: Frederikus A Klok, Scott C Woller, Aviva Schwartz, Samarth Mishra, Pantep Angchaisuksiri, Julie Bayley, Jeffrey Haber, Jackeline Hernandez-Nino, Rachael Hunter, Jeffrey A Kline, Dieuwke Luijten, Hart K MacDur, Zoubida Tazi Mezalek, Nancy Mburun, Simon Noble, Toby Richards, Ana Thereza C Rocha, Parham Sadeghipour, Rosa Talerico, Liesbeth M van Vliet, Kerstin de Wit, Grégoire Le Gal

Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
